Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Morten Hansen

Showing results (81-90 of 83) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 83 results.
JCI Insight|December 7, 2018
Metformin-induced glucagon-like peptide-1 secretion contributes to the actions of metformin in type 2 diabetesEmilie Bahne, Emily W L Sun, Richard L Young, et al.
Frontiers in Oncology|March 15, 2021
Therapeutic Cancer Vaccination With a Peptide Derived From the Calreticulin Exon 9 Mutations Induces Strong Cellular Immune Responses in Patients With <i>CALR</i>-Mutant Chronic Myeloproliferative NeoplasmsJacob Handlos Grauslund, Morten Orebo Holmström, Nicolai Grønne Jørgensen, et al.
Science Immunology|July 7, 2023
Restoring tumor immunogenicity with dendritic cell reprogrammingOlga Zimmermannova, Alexandra G Ferreira, Ervin Ascic, et al.
Pageof 9

Showing results (81-90 of 83) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 83 results.
JCI Insight|December 7, 2018
Metformin-induced glucagon-like peptide-1 secretion contributes to the actions of metformin in type 2 diabetesEmilie Bahne, Emily W L Sun, Richard L Young, et al.
Frontiers in Oncology|March 15, 2021
Therapeutic Cancer Vaccination With a Peptide Derived From the Calreticulin Exon 9 Mutations Induces Strong Cellular Immune Responses in Patients With <i>CALR</i>-Mutant Chronic Myeloproliferative NeoplasmsJacob Handlos Grauslund, Morten Orebo Holmström, Nicolai Grønne Jørgensen, et al.
Science Immunology|July 7, 2023
Restoring tumor immunogenicity with dendritic cell reprogrammingOlga Zimmermannova, Alexandra G Ferreira, Ervin Ascic, et al.
Pageof 9